These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7922036)

  • 21. Picture story. The 'serpin'ator.
    Konforti B
    Nat Struct Biol; 2000 Nov; 7(11):1005. PubMed ID: 11062552
    [No Abstract]   [Full Text] [Related]  

  • 22. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
    Peterson FC; Gettins PG
    Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity.
    Jing H; Babu YS; Moore D; Kilpatrick JM; Liu XY; Volanakis JE; Narayana SV
    J Mol Biol; 1998 Oct; 282(5):1061-81. PubMed ID: 9753554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of a serpin-protease complex shows inhibition by deformation.
    Huntington JA; Read RJ; Carrell RW
    Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two hands (or four) are better than one.
    Dunn BM; Bungert J
    Nat Biotechnol; 2003 Sep; 21(9):1019-21. PubMed ID: 12949566
    [No Abstract]   [Full Text] [Related]  

  • 26. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
    Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
    Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and comparison with the structures in crystals.
    Ludvigsen S; Shen HY; Kjaer M; Madsen JC; Poulsen FM
    J Mol Biol; 1991 Dec; 222(3):621-35. PubMed ID: 1748996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors.
    Hubbard SJ; Campbell SF; Thornton JM
    J Mol Biol; 1991 Jul; 220(2):507-30. PubMed ID: 1856871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
    Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
    FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and characterization of elastase inhibitors from the ascarid nematodes Anisakis simplex and Ascaris suum.
    Nguyen TT; Qasim MA; Morris S; Lu CC; Hill D; Laskowski M; Sakanari JA
    Mol Biochem Parasitol; 1999 Jul; 102(1):79-89. PubMed ID: 10477178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of conformational change in serpin structure and function.
    Gettins P; Patston PA; Schapira M
    Bioessays; 1993 Jul; 15(7):461-7. PubMed ID: 8379949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ecotin: lessons on survival in a protease-filled world.
    McGrath ME; Gillmor SA; Fletterick RJ
    Protein Sci; 1995 Feb; 4(2):141-8. PubMed ID: 7757004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine protease inhibitors containing a Kunitz domain: their role in modulation of host inflammatory responses and parasite survival.
    de Magalhães MTQ; Mambelli FS; Santos BPO; Morais SB; Oliveira SC
    Microbes Infect; 2018; 20(9-10):606-609. PubMed ID: 29355617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution.
    Frigerio F; Coda A; Pugliese L; Lionetti C; Menegatti E; Amiconi G; Schnebli HP; Ascenzi P; Bolognesi M
    J Mol Biol; 1992 May; 225(1):107-23. PubMed ID: 1583684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A structural mechanism of flavonoids in inhibiting serine proteases.
    Xue G; Gong L; Yuan C; Xu M; Wang X; Jiang L; Huang M
    Food Funct; 2017 Jul; 8(7):2437-2443. PubMed ID: 28644504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serine protease inhibitors (SERPINS): where mechanism meets medicine.
    Rubin H
    Nat Med; 1996 Jun; 2(6):632-3. PubMed ID: 8640547
    [No Abstract]   [Full Text] [Related]  

  • 39. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein inhibitors of serine proteinases.
    Otlewski J; Krowarsch D; Apostoluk W
    Acta Biochim Pol; 1999; 46(3):531-65. PubMed ID: 10698264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.